Related Experiment Video
Updated: Apr 18, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Child neuroanatomical, neurocognitive, and visual acuity outcomes with maternal opioid and polysubstance
Kristine B Walhovd1, Astrid Bjørnebekk1, Kristin Haabrekke2
1Research Group for Lifespan Changes in Brain and Cognition, Department of Psychology, University of Oslo, Norway; Department of Physical Medicine and Rehabilitation, Unit of Neuropsychology, Oslo University Hospital, Oslo, Norway.
Insights
Maternal detoxification during pregnancy prevented neuroanatomical and neurocognitive differences in children. However, drug-exposed children showed lower visual acuity, highlighting a need for further research on long-term outcomes.
Area of Science:
- Neuroscience
- Developmental Psychology
- Public Health
Background:
- Maternal opioid and polysubstance use during pregnancy poses risks to child neurodevelopment.
- Previous studies indicated neuroanatomical and neurocognitive differences in offspring of non-detoxified mothers.
- This study investigated outcomes in children whose mothers underwent detoxification.
Purpose of the Study:
- To determine if maternal detoxification during pregnancy mitigates neuroanatomical and neurocognitive deficits in offspring.
- To compare neurodevelopmental outcomes between children of detoxified mothers and a comparison group.
Main Methods:
- Recruited mothers with opioid/polysubstance abuse and their infants from treatment centers.
- Included a comparison group of mothers and infants from child health centers.
- Assessed children at 4.5 years using MRI, neurocognitive, and visual acuity tests.
Main Results:
- No significant differences in neuroanatomical volumes or cortical characteristics were found.
- General neurocognitive functioning did not differ between groups.
- Children exposed to drugs showed significantly lower left eye visual acuity and a trend toward lower binocular visual acuity.
Conclusions:
- Maternal detoxification appears to prevent gross neuroanatomical and neurocognitive differences in children.
- Visual acuity deficits in the drug-exposed group warrant attention and further investigation.
- Larger studies are needed to understand long-term and specific outcomes in this at-risk population.
Background:
Maternal opioid and polysubstance use during pregnancy is associated with an increased risk of child neurocognitive and visual problems and neuroanatomical differences. We hypothesized that, in contrast to findings from a previous study of children born to mothers not detoxified, children born to detoxified mothers would not show gross neuroanatomical and neurocognitive differences.
Methods:
Mothers with opioid and polysusbstance abuse problems and their infants (n = 11 + 12) were recruited from residential treatment institutions. Comparison mothers and infants (n = 12 + 12) were recruited from child health centers. The studies were approved by the Regional Committee of Medical Research Ethics. Children had magnetic resonance imaging scanning, neurocognitive, and visual acuity testing at 4.5 years. Neuroanatomical, cognitive, and visual acuity characteristics were compared across groups by analysis of variance and general linear models.
Results:
There were no significant differences across groups in neuroanatomical volumes, or cortical thickness, area, or volume. There were no differences in general neurocognitive functioning, but significantly lower left eye visual acuity, and a trend toward lower binocular visual acuity, in the drug-exposed relative to the comparison group.
Conclusions:
The present study does not demonstrate gross differences relative to a comparison group in neuroanatomical and general neurocognitive characteristics of children born to mothers with opioid and polysubstance abuse who were detoxified during pregnancy. However, visual acuity was significantly lower in the drug-exposed group, requiring attention. There is a pressing need for additional and larger studies of long-term and specific child outcomes in this at-risk group.
More Related Videos
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Factors Affecting Drug Response: Overview